Global Venous Thromboembolism Treatment Options Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Page: 99

Published Date: 02 Apr 2022

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Venous Thromboembolism Treatment Options market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Venous Thromboembolism Treatment Options market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during forecast period 2022-2028. Hospitals accounting for % of the Venous Thromboembolism Treatment Options global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Upper Pneumatic Compression Sleeves segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Venous Thromboembolism Treatment Options include AngioDynamics, Cardinal Health Inc., BTG International Ltd., Stryker Corporation, and DJO Global Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Venous Thromboembolism Treatment Options market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Upper Pneumatic Compression Sleeves
    Lower Pneumatic Compression Sleeves
    Permanent Inferior Vena Cava Filters
    Others

Market segment by Application can be divided into
    Hospitals
    Catheterisation Laboratories
    Ambulatory Surgical Centers

The key market players for global Venous Thromboembolism Treatment Options market are listed below:
    AngioDynamics
    Cardinal Health Inc.
    BTG International Ltd.
    Stryker Corporation
    DJO Global Inc.
    EKOS Corp
    Teleflex Inc., Boston Scientific Corp.
    Janssen Pharmaceuticals, Inc

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Venous Thromboembolism Treatment Options product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Venous Thromboembolism Treatment Options, with price, sales, revenue and global market share of Venous Thromboembolism Treatment Options from 2019 to 2022.
Chapter 3, the Venous Thromboembolism Treatment Options competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Venous Thromboembolism Treatment Options breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Venous Thromboembolism Treatment Options market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Venous Thromboembolism Treatment Options.
Chapter 13, 14, and 15, to describe Venous Thromboembolism Treatment Options sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Venous Thromboembolism Treatment Options Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Venous Thromboembolism Treatment Options Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Upper Pneumatic Compression Sleeves
        1.2.3 Lower Pneumatic Compression Sleeves
        1.2.4 Permanent Inferior Vena Cava Filters
        1.2.5 Others
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Venous Thromboembolism Treatment Options Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Hospitals
        1.3.3 Catheterisation Laboratories
        1.3.4 Ambulatory Surgical Centers
    1.4 Global Venous Thromboembolism Treatment Options Market Size & Forecast
        1.4.1 Global Venous Thromboembolism Treatment Options Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Venous Thromboembolism Treatment Options Sales in Volume (2017-2028)
        1.4.3 Global Venous Thromboembolism Treatment Options Price (2017-2028)
    1.5 Global Venous Thromboembolism Treatment Options Production Capacity Analysis
        1.5.1 Global Venous Thromboembolism Treatment Options Total Production Capacity (2017-2028)
        1.5.2 Global Venous Thromboembolism Treatment Options Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Venous Thromboembolism Treatment Options Market Drivers
        1.6.2 Venous Thromboembolism Treatment Options Market Restraints
        1.6.3 Venous Thromboembolism Treatment Options Trends Analysis

2 Manufacturers Profiles
    2.1 AngioDynamics
        2.1.1 AngioDynamics Details
        2.1.2 AngioDynamics Major Business
        2.1.3 AngioDynamics Venous Thromboembolism Treatment Options Product and Services
        2.1.4 AngioDynamics Venous Thromboembolism Treatment Options Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 Cardinal Health Inc.
        2.2.1 Cardinal Health Inc. Details
        2.2.2 Cardinal Health Inc. Major Business
        2.2.3 Cardinal Health Inc. Venous Thromboembolism Treatment Options Product and Services
        2.2.4 Cardinal Health Inc. Venous Thromboembolism Treatment Options Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 BTG International Ltd.
        2.3.1 BTG International Ltd. Details
        2.3.2 BTG International Ltd. Major Business
        2.3.3 BTG International Ltd. Venous Thromboembolism Treatment Options Product and Services
        2.3.4 BTG International Ltd. Venous Thromboembolism Treatment Options Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 Stryker Corporation
        2.4.1 Stryker Corporation Details
        2.4.2 Stryker Corporation Major Business
        2.4.3 Stryker Corporation Venous Thromboembolism Treatment Options Product and Services
        2.4.4 Stryker Corporation Venous Thromboembolism Treatment Options Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 DJO Global Inc.
        2.5.1 DJO Global Inc. Details
        2.5.2 DJO Global Inc. Major Business
        2.5.3 DJO Global Inc. Venous Thromboembolism Treatment Options Product and Services
        2.5.4 DJO Global Inc. Venous Thromboembolism Treatment Options Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 EKOS Corp
        2.6.1 EKOS Corp Details
        2.6.2 EKOS Corp Major Business
        2.6.3 EKOS Corp Venous Thromboembolism Treatment Options Product and Services
        2.6.4 EKOS Corp Venous Thromboembolism Treatment Options Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 Teleflex Inc., Boston Scientific Corp.
        2.7.1 Teleflex Inc., Boston Scientific Corp. Details
        2.7.2 Teleflex Inc., Boston Scientific Corp. Major Business
        2.7.3 Teleflex Inc., Boston Scientific Corp. Venous Thromboembolism Treatment Options Product and Services
        2.7.4 Teleflex Inc., Boston Scientific Corp. Venous Thromboembolism Treatment Options Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 Janssen Pharmaceuticals, Inc
        2.8.1 Janssen Pharmaceuticals, Inc Details
        2.8.2 Janssen Pharmaceuticals, Inc Major Business
        2.8.3 Janssen Pharmaceuticals, Inc Venous Thromboembolism Treatment Options Product and Services
        2.8.4 Janssen Pharmaceuticals, Inc Venous Thromboembolism Treatment Options Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Venous Thromboembolism Treatment Options Breakdown Data by Manufacturer
    3.1 Global Venous Thromboembolism Treatment Options Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Venous Thromboembolism Treatment Options Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Venous Thromboembolism Treatment Options
    3.4 Market Concentration Rate
        3.4.1 Top 3 Venous Thromboembolism Treatment Options Manufacturer Market Share in 2021
        3.4.2 Top 6 Venous Thromboembolism Treatment Options Manufacturer Market Share in 2021
    3.5 Global Venous Thromboembolism Treatment Options Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Venous Thromboembolism Treatment Options Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Venous Thromboembolism Treatment Options Market Size by Region
        4.1.1 Global Venous Thromboembolism Treatment Options Sales in Volume by Region (2017-2028)
        4.1.2 Global Venous Thromboembolism Treatment Options Revenue by Region (2017-2028)
    4.2 North America Venous Thromboembolism Treatment Options Revenue (2017-2028)
    4.3 Europe Venous Thromboembolism Treatment Options Revenue (2017-2028)
    4.4 Asia-Pacific Venous Thromboembolism Treatment Options Revenue (2017-2028)
    4.5 South America Venous Thromboembolism Treatment Options Revenue (2017-2028)
    4.6 Middle East and Africa Venous Thromboembolism Treatment Options Revenue (2017-2028)

5 Market Segment by Type
    5.1 Global Venous Thromboembolism Treatment Options Sales in Volume by Type (2017-2028)
    5.2 Global Venous Thromboembolism Treatment Options Revenue by Type (2017-2028)
    5.3 Global Venous Thromboembolism Treatment Options Price by Type (2017-2028)

6 Market Segment by Application
    6.1 Global Venous Thromboembolism Treatment Options Sales in Volume by Application (2017-2028)
    6.2 Global Venous Thromboembolism Treatment Options Revenue by Application (2017-2028)
    6.3 Global Venous Thromboembolism Treatment Options Price by Application (2017-2028)

7 North America by Country, by Type, and by Application
    7.1 North America Venous Thromboembolism Treatment Options Sales by Type (2017-2028)
    7.2 North America Venous Thromboembolism Treatment Options Sales by Application (2017-2028)
    7.3 North America Venous Thromboembolism Treatment Options Market Size by Country
        7.3.1 North America Venous Thromboembolism Treatment Options Sales in Volume by Country (2017-2028)
        7.3.2 North America Venous Thromboembolism Treatment Options Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application
    8.1 Europe Venous Thromboembolism Treatment Options Sales by Type (2017-2028)
    8.2 Europe Venous Thromboembolism Treatment Options Sales by Application (2017-2028)
    8.3 Europe Venous Thromboembolism Treatment Options Market Size by Country
        8.3.1 Europe Venous Thromboembolism Treatment Options Sales in Volume by Country (2017-2028)
        8.3.2 Europe Venous Thromboembolism Treatment Options Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Venous Thromboembolism Treatment Options Sales by Type (2017-2028)
    9.2 Asia-Pacific Venous Thromboembolism Treatment Options Sales by Application (2017-2028)
    9.3 Asia-Pacific Venous Thromboembolism Treatment Options Market Size by Region
        9.3.1 Asia-Pacific Venous Thromboembolism Treatment Options Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Venous Thromboembolism Treatment Options Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application
    10.1 South America Venous Thromboembolism Treatment Options Sales by Type (2017-2028)
    10.2 South America Venous Thromboembolism Treatment Options Sales by Application (2017-2028)
    10.3 South America Venous Thromboembolism Treatment Options Market Size by Country
        10.3.1 South America Venous Thromboembolism Treatment Options Sales in Volume by Country (2017-2028)
        10.3.2 South America Venous Thromboembolism Treatment Options Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Venous Thromboembolism Treatment Options Sales by Type (2017-2028)
    11.2 Middle East & Africa Venous Thromboembolism Treatment Options Sales by Application (2017-2028)
    11.3 Middle East & Africa Venous Thromboembolism Treatment Options Market Size by Country
        11.3.1 Middle East & Africa Venous Thromboembolism Treatment Options Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Venous Thromboembolism Treatment Options Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain
    12.1 Raw Material of Venous Thromboembolism Treatment Options and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Venous Thromboembolism Treatment Options
    12.3 Venous Thromboembolism Treatment Options Production Process
    12.4 Venous Thromboembolism Treatment Options Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Venous Thromboembolism Treatment Options Typical Distributors
    13.3 Venous Thromboembolism Treatment Options Typical Customers

14 Research Findings and Conclusion

15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Venous Thromboembolism Treatment Options Revenue by Type, (USD Million), 2017 & 2021 & 2028
    Table 2. Global Venous Thromboembolism Treatment Options Revenue by Application, (USD Million), 2017 & 2021 & 2028
    Table 3. AngioDynamics Basic Information, Manufacturing Base and Competitors
    Table 4. AngioDynamics Major Business
    Table 5. AngioDynamics Venous Thromboembolism Treatment Options Product and Services
    Table 6. AngioDynamics Venous Thromboembolism Treatment Options Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 7. Cardinal Health Inc. Basic Information, Manufacturing Base and Competitors
    Table 8. Cardinal Health Inc. Major Business
    Table 9. Cardinal Health Inc. Venous Thromboembolism Treatment Options Product and Services
    Table 10. Cardinal Health Inc. Venous Thromboembolism Treatment Options Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 11. BTG International Ltd. Basic Information, Manufacturing Base and Competitors
    Table 12. BTG International Ltd. Major Business
    Table 13. BTG International Ltd. Venous Thromboembolism Treatment Options Product and Services
    Table 14. BTG International Ltd. Venous Thromboembolism Treatment Options Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 15. Stryker Corporation Basic Information, Manufacturing Base and Competitors
    Table 16. Stryker Corporation Major Business
    Table 17. Stryker Corporation Venous Thromboembolism Treatment Options Product and Services
    Table 18. Stryker Corporation Venous Thromboembolism Treatment Options Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 19. DJO Global Inc. Basic Information, Manufacturing Base and Competitors
    Table 20. DJO Global Inc. Major Business
    Table 21. DJO Global Inc. Venous Thromboembolism Treatment Options Product and Services
    Table 22. DJO Global Inc. Venous Thromboembolism Treatment Options Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 23. EKOS Corp Basic Information, Manufacturing Base and Competitors
    Table 24. EKOS Corp Major Business
    Table 25. EKOS Corp Venous Thromboembolism Treatment Options Product and Services
    Table 26. EKOS Corp Venous Thromboembolism Treatment Options Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 27. Teleflex Inc., Boston Scientific Corp. Basic Information, Manufacturing Base and Competitors
    Table 28. Teleflex Inc., Boston Scientific Corp. Major Business
    Table 29. Teleflex Inc., Boston Scientific Corp. Venous Thromboembolism Treatment Options Product and Services
    Table 30. Teleflex Inc., Boston Scientific Corp. Venous Thromboembolism Treatment Options Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 31. Janssen Pharmaceuticals, Inc Basic Information, Manufacturing Base and Competitors
    Table 32. Janssen Pharmaceuticals, Inc Major Business
    Table 33. Janssen Pharmaceuticals, Inc Venous Thromboembolism Treatment Options Product and Services
    Table 34. Janssen Pharmaceuticals, Inc Venous Thromboembolism Treatment Options Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 35. Global Venous Thromboembolism Treatment Options Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
    Table 36. Global Venous Thromboembolism Treatment Options Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
    Table 37. Market Position of Manufacturers in Venous Thromboembolism Treatment Options, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
    Table 38. Global Venous Thromboembolism Treatment Options Production Capacity by Company, (K Units): 2020 VS 2021
    Table 39. Head Office and Venous Thromboembolism Treatment Options Production Site of Key Manufacturer
    Table 40. Venous Thromboembolism Treatment Options New Entrant and Capacity Expansion Plans
    Table 41. Venous Thromboembolism Treatment Options Mergers & Acquisitions in the Past Five Years
    Table 42. Global Venous Thromboembolism Treatment Options Sales by Region (2017-2022) & (K Units)
    Table 43. Global Venous Thromboembolism Treatment Options Sales by Region (2023-2028) & (K Units)
    Table 44. Global Venous Thromboembolism Treatment Options Revenue by Region (2017-2022) & (USD Million)
    Table 45. Global Venous Thromboembolism Treatment Options Revenue by Region (2023-2028) & (USD Million)
    Table 46. Global Venous Thromboembolism Treatment Options Sales by Type (2017-2022) & (K Units)
    Table 47. Global Venous Thromboembolism Treatment Options Sales by Type (2023-2028) & (K Units)
    Table 48. Global Venous Thromboembolism Treatment Options Revenue by Type (2017-2022) & (USD Million)
    Table 49. Global Venous Thromboembolism Treatment Options Revenue by Type (2023-2028) & (USD Million)
    Table 50. Global Venous Thromboembolism Treatment Options Price by Type (2017-2022) & (US$/Unit)
    Table 51. Global Venous Thromboembolism Treatment Options Price by Type (2023-2028) & (US$/Unit)
    Table 52. Global Venous Thromboembolism Treatment Options Sales by Application (2017-2022) & (K Units)
    Table 53. Global Venous Thromboembolism Treatment Options Sales by Application (2023-2028) & (K Units)
    Table 54. Global Venous Thromboembolism Treatment Options Revenue by Application (2017-2022) & (USD Million)
    Table 55. Global Venous Thromboembolism Treatment Options Revenue by Application (2023-2028) & (USD Million)
    Table 56. Global Venous Thromboembolism Treatment Options Price by Application (2017-2022) & (US$/Unit)
    Table 57. Global Venous Thromboembolism Treatment Options Price by Application (2023-2028) & (US$/Unit)
    Table 58. North America Venous Thromboembolism Treatment Options Sales by Country (2017-2022) & (K Units)
    Table 59. North America Venous Thromboembolism Treatment Options Sales by Country (2023-2028) & (K Units)
    Table 60. North America Venous Thromboembolism Treatment Options Revenue by Country (2017-2022) & (USD Million)
    Table 61. North America Venous Thromboembolism Treatment Options Revenue by Country (2023-2028) & (USD Million)
    Table 62. North America Venous Thromboembolism Treatment Options Sales by Type (2017-2022) & (K Units)
    Table 63. North America Venous Thromboembolism Treatment Options Sales by Type (2023-2028) & (K Units)
    Table 64. North America Venous Thromboembolism Treatment Options Sales by Application (2017-2022) & (K Units)
    Table 65. North America Venous Thromboembolism Treatment Options Sales by Application (2023-2028) & (K Units)
    Table 66. Europe Venous Thromboembolism Treatment Options Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Venous Thromboembolism Treatment Options Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Venous Thromboembolism Treatment Options Revenue by Country (2017-2022) & (USD Million)
    Table 69. Europe Venous Thromboembolism Treatment Options Revenue by Country (2023-2028) & (USD Million)
    Table 70. Europe Venous Thromboembolism Treatment Options Sales by Type (2017-2022) & (K Units)
    Table 71. Europe Venous Thromboembolism Treatment Options Sales by Type (2023-2028) & (K Units)
    Table 72. Europe Venous Thromboembolism Treatment Options Sales by Application (2017-2022) & (K Units)
    Table 73. Europe Venous Thromboembolism Treatment Options Sales by Application (2023-2028) & (K Units)
    Table 74. Asia-Pacific Venous Thromboembolism Treatment Options Sales by Region (2017-2022) & (K Units)
    Table 75. Asia-Pacific Venous Thromboembolism Treatment Options Sales by Region (2023-2028) & (K Units)
    Table 76. Asia-Pacific Venous Thromboembolism Treatment Options Revenue by Region (2017-2022) & (USD Million)
    Table 77. Asia-Pacific Venous Thromboembolism Treatment Options Revenue by Region (2023-2028) & (USD Million)
    Table 78. Asia-Pacific Venous Thromboembolism Treatment Options Sales by Type (2017-2022) & (K Units)
    Table 79. Asia-Pacific Venous Thromboembolism Treatment Options Sales by Type (2023-2028) & (K Units)
    Table 80. Asia-Pacific Venous Thromboembolism Treatment Options Sales by Application (2017-2022) & (K Units)
    Table 81. Asia-Pacific Venous Thromboembolism Treatment Options Sales by Application (2023-2028) & (K Units)
    Table 82. South America Venous Thromboembolism Treatment Options Sales by Country (2017-2022) & (K Units)
    Table 83. South America Venous Thromboembolism Treatment Options Sales by Country (2023-2028) & (K Units)
    Table 84. South America Venous Thromboembolism Treatment Options Revenue by Country (2017-2022) & (USD Million)
    Table 85. South America Venous Thromboembolism Treatment Options Revenue by Country (2023-2028) & (USD Million)
    Table 86. South America Venous Thromboembolism Treatment Options Sales by Type (2017-2022) & (K Units)
    Table 87. South America Venous Thromboembolism Treatment Options Sales by Type (2023-2028) & (K Units)
    Table 88. South America Venous Thromboembolism Treatment Options Sales by Application (2017-2022) & (K Units)
    Table 89. South America Venous Thromboembolism Treatment Options Sales by Application (2023-2028) & (K Units)
    Table 90. Middle East & Africa Venous Thromboembolism Treatment Options Sales by Region (2017-2022) & (K Units)
    Table 91. Middle East & Africa Venous Thromboembolism Treatment Options Sales by Region (2023-2028) & (K Units)
    Table 92. Middle East & Africa Venous Thromboembolism Treatment Options Revenue by Region (2017-2022) & (USD Million)
    Table 93. Middle East & Africa Venous Thromboembolism Treatment Options Revenue by Region (2023-2028) & (USD Million)
    Table 94. Middle East & Africa Venous Thromboembolism Treatment Options Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East & Africa Venous Thromboembolism Treatment Options Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East & Africa Venous Thromboembolism Treatment Options Sales by Application (2017-2022) & (K Units)
    Table 97. Middle East & Africa Venous Thromboembolism Treatment Options Sales by Application (2023-2028) & (K Units)
    Table 98. Venous Thromboembolism Treatment Options Raw Material
    Table 99. Key Manufacturers of Venous Thromboembolism Treatment Options Raw Materials
    Table 100. Direct Channel Pros & Cons
    Table 101. Indirect Channel Pros & Cons
    Table 102. Venous Thromboembolism Treatment Options Typical Distributors
    Table 103. Venous Thromboembolism Treatment Options Typical Customers
List of Figures
    Figure 1. Venous Thromboembolism Treatment Options Picture
    Figure 2. Global Venous Thromboembolism Treatment Options Revenue Market Share by Type in 2021
    Figure 3. Upper Pneumatic Compression Sleeves
    Figure 4. Lower Pneumatic Compression Sleeves
    Figure 5. Permanent Inferior Vena Cava Filters
    Figure 6. Others
    Figure 7. Global Venous Thromboembolism Treatment Options Revenue Market Share by Application in 2021
    Figure 8. Hospitals
    Figure 9. Catheterisation Laboratories
    Figure 10. Ambulatory Surgical Centers
    Figure 11. Global Venous Thromboembolism Treatment Options Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
    Figure 12. Global Venous Thromboembolism Treatment Options Revenue and Forecast (2017-2028) & (USD Million)
    Figure 13. Global Venous Thromboembolism Treatment Options Sales (2017-2028) & (K Units)
    Figure 14. Global Venous Thromboembolism Treatment Options Price (2017-2028) & (US$/Unit)
    Figure 15. Global Venous Thromboembolism Treatment Options Production Capacity (2017-2028) & (K Units)
    Figure 16. Global Venous Thromboembolism Treatment Options Production Capacity by Geographic Region: 2022 VS 2028
    Figure 17. Venous Thromboembolism Treatment Options Market Drivers
    Figure 18. Venous Thromboembolism Treatment Options Market Restraints
    Figure 19. Venous Thromboembolism Treatment Options Market Trends
    Figure 20. Global Venous Thromboembolism Treatment Options Sales Market Share by Manufacturer in 2021
    Figure 21. Global Venous Thromboembolism Treatment Options Revenue Market Share by Manufacturer in 2021
    Figure 22. Venous Thromboembolism Treatment Options Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
    Figure 23. Top 3 Venous Thromboembolism Treatment Options Manufacturer (Revenue) Market Share in 2021
    Figure 24. Top 6 Venous Thromboembolism Treatment Options Manufacturer (Revenue) Market Share in 2021
    Figure 25. Global Venous Thromboembolism Treatment Options Sales Market Share by Region (2017-2028)
    Figure 26. Global Venous Thromboembolism Treatment Options Revenue Market Share by Region (2017-2028)
    Figure 27. North America Venous Thromboembolism Treatment Options Revenue (2017-2028) & (USD Million)
    Figure 28. Europe Venous Thromboembolism Treatment Options Revenue (2017-2028) & (USD Million)
    Figure 29. Asia-Pacific Venous Thromboembolism Treatment Options Revenue (2017-2028) & (USD Million)
    Figure 30. South America Venous Thromboembolism Treatment Options Revenue (2017-2028) & (USD Million)
    Figure 31. Middle East & Africa Venous Thromboembolism Treatment Options Revenue (2017-2028) & (USD Million)
    Figure 32. Global Venous Thromboembolism Treatment Options Sales Market Share by Type (2017-2028)
    Figure 33. Global Venous Thromboembolism Treatment Options Revenue Market Share by Type (2017-2028)
    Figure 34. Global Venous Thromboembolism Treatment Options Price by Type (2017-2028) & (US$/Unit)
    Figure 35. Global Venous Thromboembolism Treatment Options Sales Market Share by Application (2017-2028)
    Figure 36. Global Venous Thromboembolism Treatment Options Revenue Market Share by Application (2017-2028)
    Figure 37. Global Venous Thromboembolism Treatment Options Price by Application (2017-2028) & (US$/Unit)
    Figure 38. North America Venous Thromboembolism Treatment Options Sales Market Share by Type (2017-2028)
    Figure 39. North America Venous Thromboembolism Treatment Options Sales Market Share by Application (2017-2028)
    Figure 40. North America Venous Thromboembolism Treatment Options Sales Market Share by Country (2017-2028)
    Figure 41. North America Venous Thromboembolism Treatment Options Revenue Market Share by Country (2017-2028)
    Figure 42. United States Venous Thromboembolism Treatment Options Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 43. Canada Venous Thromboembolism Treatment Options Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 44. Mexico Venous Thromboembolism Treatment Options Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 45. Europe Venous Thromboembolism Treatment Options Sales Market Share by Type (2017-2028)
    Figure 46. Europe Venous Thromboembolism Treatment Options Sales Market Share by Application (2017-2028)
    Figure 47. Europe Venous Thromboembolism Treatment Options Sales Market Share by Country (2017-2028)
    Figure 48. Europe Venous Thromboembolism Treatment Options Revenue Market Share by Country (2017-2028)
    Figure 49. Germany Venous Thromboembolism Treatment Options Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 50. France Venous Thromboembolism Treatment Options Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 51. United Kingdom Venous Thromboembolism Treatment Options Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 52. Russia Venous Thromboembolism Treatment Options Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 53. Italy Venous Thromboembolism Treatment Options Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 54. Asia-Pacific Venous Thromboembolism Treatment Options Sales Market Share by Region (2017-2028)
    Figure 55. Asia-Pacific Venous Thromboembolism Treatment Options Sales Market Share by Application (2017-2028)
    Figure 56. Asia-Pacific Venous Thromboembolism Treatment Options Sales Market Share by Region (2017-2028)
    Figure 57. Asia-Pacific Venous Thromboembolism Treatment Options Revenue Market Share by Region (2017-2028)
    Figure 58. China Venous Thromboembolism Treatment Options Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 59. Japan Venous Thromboembolism Treatment Options Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 60. Korea Venous Thromboembolism Treatment Options Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. India Venous Thromboembolism Treatment Options Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 62. Southeast Asia Venous Thromboembolism Treatment Options Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 63. Australia Venous Thromboembolism Treatment Options Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 64. South America Venous Thromboembolism Treatment Options Sales Market Share by Type (2017-2028)
    Figure 65. South America Venous Thromboembolism Treatment Options Sales Market Share by Application (2017-2028)
    Figure 66. South America Venous Thromboembolism Treatment Options Sales Market Share by Country (2017-2028)
    Figure 67. South America Venous Thromboembolism Treatment Options Revenue Market Share by Country (2017-2028)
    Figure 68. Brazil Venous Thromboembolism Treatment Options Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 69. Argentina Venous Thromboembolism Treatment Options Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 70. Middle East & Africa Venous Thromboembolism Treatment Options Sales Market Share by Type (2017-2028)
    Figure 71. Middle East & Africa Venous Thromboembolism Treatment Options Sales Market Share by Application (2017-2028)
    Figure 72. Middle East & Africa Venous Thromboembolism Treatment Options Sales Market Share by Region (2017-2028)
    Figure 73. Middle East & Africa Venous Thromboembolism Treatment Options Revenue Market Share by Region (2017-2028)
    Figure 74. Turkey Venous Thromboembolism Treatment Options Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 75. Egypt Venous Thromboembolism Treatment Options Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 76. Saudi Arabia Venous Thromboembolism Treatment Options Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 77. South Africa Venous Thromboembolism Treatment Options Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 78. Manufacturing Cost Structure Analysis of Venous Thromboembolism Treatment Options in 2021
    Figure 79. Manufacturing Process Analysis of Venous Thromboembolism Treatment Options
    Figure 80. Venous Thromboembolism Treatment Options Industrial Chain
    Figure 81. Sales Channel: Direct Channel vs Indirect Channel
    Figure 82. Methodology
    Figure 83. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

AngioDynamics
Cardinal Health Inc.
BTG International Ltd.
Stryker Corporation
DJO Global Inc.
EKOS Corp
Teleflex Inc., Boston Scientific Corp.
Janssen Pharmaceuticals, Inc

Related Reports

Global Venous Thromboembolism Treatment Options Supply, Demand and Key Producers, 2023-2029

Global Venous Thromboembolism Treatment Options Supply, Demand and Key Producers, 2023-2029

date 04 Sep 2023

date Medical Care

The global Venous Thromboembolism Treatment Options market size is expected to reach $ 462 million by 2029, rising at a market growth of 3.3% CAGR during the forecast period (2023-2029).

Global Venous Thromboembolism Treatment Options Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Venous Thromboembolism Treatment Options Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 04 Sep 2023

date Medical Care

According to our (Global Info Research) latest study, the global Venous Thromboembolism Treatment Options market size was valued at USD 366.8 million in 2022 and is forecast to a readjusted size of USD 462 million by 2029 with a CAGR of 3.3% during review period.

Global Venous Thromboembolism Treatment Options Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Venous Thromboembolism Treatment Options Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 17 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Venous Thromboembolism Treatment Options market size was valued at USD 366.8 million in 2023 and is forecast to a readjusted size of USD 462 million by 2030 with a CAGR of 3.3% during review period.

Product Tags

venous thromboembolism treatment options

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>